1. Antibody-drug Conjugate/ADC Related Protein Tyrosine Kinase/RTK
  2. Antibody-Drug Conjugates (ADCs) TAM Receptor
  3. Enapotamab vedotin

Enapotamab vedotin is an AXL-targeted antibody-drug conjugate (ADC) with inhibitory potential against high AXL expressing non-small cell lung cancer (NSCLC). Enapotamab vedotin also exhibits resistant to EGFR inhibitor such as Osimertinib (HY-15772).

For research use only. We do not sell to patients.

Enapotamab vedotin Chemical Structure

Enapotamab vedotin Chemical Structure

CAS No. : 1912424-97-5

Size Stock
1 mg   Get quote  
5 mg   Get quote  
10 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All TAM Receptor Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Enapotamab vedotin is an AXL-targeted antibody-drug conjugate (ADC) with inhibitory potential against high AXL expressing non-small cell lung cancer (NSCLC). Enapotamab vedotin also exhibits resistant to EGFR inhibitor such as Osimertinib (HY-15772)[1].

IC50 & Target

AXL[1]

In Vitro

Enapotamab vedotin (0-10 μg/mL, 5 days) exhibits cytotoxicity in cells with high AXL expression such as ER20 and H1975-OR2, and reduces the cell viability[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: ER20, H1975-OR2
Concentration: 0-10 μg/mL
Incubation Time: 5 days
Result: Reduced the cell viability.
In Vivo

Enapotamab vedotin (2-4 mg/kg, iv, once weekly for 2 doses) exhibits antitumor efficacy against various non-small cell lung cancer (NSCLC) with high AXL expression such as LU0395, exhibits resistant to EGFR inhibitor in LU1868 or LU0858 xenograft mouse models[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: LU0395 xenograft mouse models[1]
Dosage: 2-4 mg/kg
Administration: iv, once weekly for 2 doses
Result: Inhibited the tumor growth.
CAS No.
SMILES

[Enapotamab vedotin]

Shipping

Shipping with dry ice.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Enapotamab vedotin
Cat. No.:
HY-P99921
Quantity:
MCE Japan Authorized Agent: